In extreme cases: FDA approves anti-malarial medication for COVID-19
Scientists warn against excessive hype around medicines that have not yet been tested, writes "Voice of America".
The United States Food and Drug Administration (FDA) has approved the limited emergency use of two antimalarial drugs to treat patients with coronavirus. Earlier, President Donald Trump said that these medicines will help turn the tide with the epidemic.
A ministry of health and social services statement on Sunday said recent donations to the state reserve of medicines, including drugs such as chloroquine and hydroxychloroquine, are being tested as possible drugs for treating COVID-19.
“On March 29, the US Department of Health and Human Services (HHS) took 30 million doses of hydroxychloroquine sulfate donated by Sandoz to the Novartis generic and bioanalogue department and 1 million doses of chlorohydrogen phosphate donated by Bayer Pharmaceuticals for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials. These and other companies can donate additional doses, and the companies increased production to ensure additional deliveries of the drug to the commercial market, ” official statement.
The statement said the department allowed "doctors to prescribe them to hospitalized teens and adults with COVID-19, depending on the circumstances when the clinical trial is unavailable or unacceptable."
March 23, Trump saidthat these two medicines may turn out to be a “gift of God,” although scientists warn of the dangers of excessive hype around unverified drugs.
Many researchers, including U.S. leading infectious disease expert Anthony Fauci, have called on the public to remain cautious until larger trials confirm small studies.
Two US medical organizations, the National Institutes of Health and the Office of Advanced Biomedical Research and Development, are currently planning such trials.
On the subject: 6 states with the highest risk of complications with COVID-19
Some members of the scientific community fear that Trump's positive assessment of these drugs may lead to a deficiency for patients who need them to treat lupus and rheumatoid arthritis, the diseases for which they are approved.
According to Johns Hopkins University, in the United States recorded more than 140 thousand cases of coronavirus and 2489 deaths.
stdClass Object ([term_id] => 12 [name] => In the US [taxonomy] => category [slug] => novosti-ssha)In the U.S.
stdClass Object ([term_id] => 1375 [name] => treatment [taxonomy] => post_tag [slug] => lechenie)treatment
stdClass Object ([term_id] => 28340 [name] => coronavirus [taxonomy] => post_tag [slug] => koronavirus)coronavirus
stdClass Object ([term_id] => 28347 [name] => Special projects [taxonomy] => category [slug] => specproekty)Special Projects
stdClass Object ([term_id] => 28353 [name] => Coronavirus 2019-nCoV [taxonomy] => special [slug] => kitajskij-koronavirus)
Read also on ForumDaily:
Let's face the crisis together and support each other
No one in the world expected a coronavirus pandemic, but she came in disrupting the usual rhythm of life and work of billions of people, causing panic and uncertainty about tomorrow.
ForumDaily also faced financial difficulties due to the loss of some advertisers due to the economic downturn and quarantine. But we are not reducing the number of materials and the mode of operation, since we want our readers to receive timely and up-to-date information in this difficult time. In addition, we support Local small businesses in the USA that suffer the most.
But ForumDaily is also a small business. Despite the loss of part of the income, we are doing our best to ensure that you are informed and armed with all the necessary knowledge to counter the pandemic and resolve other important issues during quarantine.
To maintain this rhythm of work, we need your help. We will be grateful for any amount that you are willing to allot to support our team.
Let's face the crisis together!
Security of contributions is guaranteed by the use of the highly secure Stripe system.
Always yours, ForumDaily!
Do you want more important and interesting news about life in the USA and immigration to America? Subscribe to our page in Facebook. Choose the option "Priority in the show" - and read us first. And don't forget to subscribe to ForumDaily Woman and ForumDaily New York - there you will find a lot of interesting and positive information.